Not logged inMinimal residual disease assessment through ctDNA facilitates tailored immunotherapy in MSI-high, NTRK1-fusion pancreatic adenocarcinoma
Rohlfing, Sarah; Vladimirova, Dilyana; Berger, Stephanie; Bochum, Sylvia; Otmacic, Gabrijela; Weiss, Marlene; Sipos, Bence; Biskup, Saskia; Klaumunzer, Marion; Martens, Uwe M. .png)
Share.png)
SavePrognostic Value of Functional Capacity in Different Exercise ProtocolsHarb, Serge C.; Bhat, Pavan; Cremer, Paul C.; Wu, Yuping; Cremer, Laura J.; Berger, Stephanie; Cho, Leslie; Menon, Venu; Gulati, Martha; Jaber, Wael A. Share Save Share Save Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancerBerger, Stephanie; Procko, Erik; Margineantu, Daciana; Lee, Erinna F.; Shen, Betty W.; Zelter, Alex; Silva, Daniel-Adriano; Chawla, Kusum; Herold, Marco J.; Gamier, Jean-Marc; Johnson, Richard; MacCoss, Michael J.; Lessene, Guillaume; Davis, Trisha N.; Stayton, Patrick S.; Stoddard, Barry L.; Fairlie, W. Douglas; Hockenbery, David M.; Baker, David Share Save Share Save Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}